Fibroblast Growth Factor-21 (FGF-21) ELISA
BioMarkers | Diabetic Nephropathy | Inflammation
Description
The K-ASSAY®Human fibroblast growth factor-21 (FGF-21) ELISA is an enzyme-linked immunosorbent assay for the quantitative determination of FGF21 in human cell culture supernatant, serum and plasma.
FGF family members possess broad mitogenic and cell survival activities relevant to biological processes, such as cell growth and tissue repair. FGF21 is induced by prolonged fasting to regulate glucose and fatty acid metabolism.
Increased circulating FGF21 levels are observed in metabolic diseases, including type 2 diabetes, obesity and nonalcoholic steatohepatitis (NASH) as well as chronic kidney disease.
Specifications
Species reactivity | Human |
Sample type | Cell culture supernatant, serum, plasma |
Assay type | Sandwich (quantitative) |
Range | 31.2–2,000 pg/mL |
Detection method | Colormetric |
Assay time | 4h 30min |
Request Quote/More Information
Check also our collection of ANIMAL FGF-21 ELISA Kits
Partner: Kamiya BioMedical Company
FGF-21 ELISA - Product Insert | "Research Use Only"
Diabetic Nephropathy - BioMarker Overview
Download the BioMarker Overview Table here, including detailed information about 28 suggested biomarker assays.
Request Quote / Request More Information
Are You Working with CRISPRs, ZFNs or TALENs?
Genome Editing Tools and Services:
- 100 % Gene Expression Control using the TUNR Flexible Gene Editing System.
- Create your own Disease Zebrafish Model powered by ZeClinics.
- Optimize your Detection of Insertions and Deletions (INDELS) using the IDAA Method.
Read more in our Genome Editing Resources section.
